PUR Biologics is a biotechnology startup founded in 2013, headquartered in the United States. With the slogan "The Authority in Ortho and Spinal Biologics," the company operates under HippoFi’s Regenerative Therapeutic division, offering a range of innovative biological products and proprietary technologies. These products are designed for bone growth in surgical spine procedures, comprising patented bioactive cellular matrix compositions and advanced autologous cell therapies to regenerate cartilage in joints and spinal discs.
The company's commitment to using only the highest quality materials and manufacturing processes reflects its dedication to providing state-of-the-art biologic solutions to medical care facilities globally. However, there is no public information available regarding the last investment and investors associated with PUR Biologics as of now.
In conclusion, PUR Biologics presents a compelling offering within the biotechnology and healthcare industries, serving a critical need for innovative solutions in orthopedic and spinal biotherapeutics. While the current lack of information about recent investment activities leaves us curious about the company’s financial partnerships, the potential impact of its pioneering products on the medical field is noteworthy.
Taxonomy:
Orthopedics, Biologics, Regenerative Medicine, Spine Surgery, Bone Growth, Biological Products, Cellular Matrix Compositions, Autologous Cell Therapies, Regenerating Cartilage, Medical Care, Regenerative Therapeutics, Manufacturing Processes, Innovative Technology